COLLAGENASE IN THE TREATMENT OF DUPUYTREN'S DISEASE

胶原酶治疗掌腱膜挛缩症

• 批准号: 7375320
• 负责人: MARIE A BADALAMENTE
• 金额: $ 2万
• 依托单位: STATE UNIVERSITY NEW YORK STONY BROOK
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7375320
• 关键词: COLLAGENASE; TREATMENT; DUPUYTREN; DISEASE

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. A Phase II random, placebo double blind trial of injectable collagenase is being studied as a non-operative treatment for Dupuytren's disease, a fixed flexion contracture deformity of the hand. This therapy may obviate the need for surgical fascioectomy for Dupuytren's disease.

本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者（PI）可能已经从另一个NIH来源获得了主要资金，因此可以在其他CRISP条目中表示。列出的机构是中心的，不一定是研究者的机构。一项II期随机、安慰剂双盲试验正在研究注射胶原酶作为治疗手部固定屈曲挛缩畸形Dupuytren病的非手术治疗方法。这种治疗方法可以避免对Dupuytren病进行外科筋膜切除术。